Another excellent review by John Ingram, CCP of various ECMO cannulation strategies, including basic cannulation and exotic cannulation strategies | Perfusion
Deeper look at Continuous Veno-Venous Hemofiltration and examine the advantages of CVVH over Intermittent Hemodialysis for the removal of pro-inflammatory mediators
Joe Basha, CCP and Minh Tran, CCP review what Continuous Veno-Venous Hemofiltration (CVVH) is and the differences between CVVH and Intermittent Hemodialysis (IHD)
The effect of Cardiopulmonary Bypass (CPB) on Platelets. Preoperative C-reactive protein as a predictor of postoperative AKI. Blood Storage Effects on the Blood Components
Minimally Invasive Mitral Valve surgery is an excellent technique to correct a problem with the valve that removes the risks associated with sternotomy
Single Ventricle physiology and how this affects perfusion technique during surgical correction. Alternative techniques to long acting cardioplegia for myocardial protection CPB
Examines the "art" of perfusion and how the perfusionist uses available data and techniques to provide sufficient perfusion and oxygenation to the patient
Update on ECMO for COVID-19: What have we learned? Early experience of pump-controlled retrograde trial off for weaning from (VA ECMO) in adult patients with cardiogenic shock
What we have learned about the health-care delivery industry through the COVID-19 pandemic. The goal is to offer provocative opinions, based on real world data, on what we did
Perfusion department management: How to best utilize resources. Faculty: J. Hoffman, MD, Matt Warhoover, CCP, A. Lepore, CCP; John Ingram Knowledge Nuggets: Haptoglobin
The Vanderbilt team - The heart transplant program at VUMC; T. Sparacino - an unusual case of neurologic recovery after protracted cardiac arrest. J. Ingram - the use of Albumin
Joe will look at the economic side of perfusion. Hospital costs, reimbursements, salaries, and how perfusion service makes money for a hospital or as a business
Tammy Sparacino, CCP describes the latest peer reviewed publications on the Cytosorb hemoadsorption technology. Hemoadsorption of apixaban during emergent CPB